Kidney-on-a-chip is a type of organ-on-a-chip (OoC) technology [7] that replicates the functions of the human kidney on a microfluidic chip. The kidney-on-a-chip consists of a transparent polymer membrane that is lined with living kidney cells, including nephrons and blood vessels, and microchannels that simulate the urine flow and mechanical forces present in the kidney.
The kidney-on-a-chip technology aims to provide a more accurate and reliable platform for drug discovery, toxicity testing, and disease modeling for kidney-related diseases such as kidney injury, chronic kidney disease (CKD), and renal fibrosis. Researchers can use the kidney-on-a-chip technology to study the effects of various drugs, toxins, and diseases on kidney function and disease development, as well as to test the safety and efficacy of new drugs before human clinical trials.
Moreover, the kidney-on-a-chip technology has the potential to revolutionize the field of regenerative medicine. By creating a platform that mimics the structure and function of the kidney, researchers can study the behavior of stem cells and other cell types in a microenvironment that is similar to kidney tissue, and develop new strategies for repairing damaged kidney tissue or even creating new kidney tissue for transplantation.
Scientists have used a "kidney on a chip" device to mimic the flow of medication through human kidneys, a technique that may lead to more precise dosing of drugs, including some toxic medicines used in ICU. Precise dosing in intensive care units (ICU) is critical, as up to two-thirds of patients in the ICU experience serious kidney injury.
Report Highlights
The global Kidney-on-a-chip market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Renal cells and nephrons have already been simulated by microfluidic devices. "Such cell cultures can lead to new insights into cell and organ function and be used for drug screening". A kidney-on-a-chip device has the potential to accelerate research encompassing artificial replacement for lost kidney function. Nowadays, dialysis requires patients to go to a clinic up to three times per week. A more transportable and accessible form of treatment would not only increase the patient鈥檚 overall health (by increasing frequency of treatment), but the whole process would become more efficient and tolerable. Artificial kidney research is striving to bring transportability, wearability and perhaps implantation capability to the devices through innovative disciplines: microfluidics, miniaturization, and nanotechnology.
Report Scope
By Company
Segment by Type
Segment by Application
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney-on-a-chip companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney-on-a-chip Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Child Kidney-on-a-chip
1.2.3 Adult Kidney-on-a-chip
1.3 Market by Application
1.3.1 Global Kidney-on-a-chip Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney-on-a-chip Market Perspective (2018-2029)
2.2 Kidney-on-a-chip Growth Trends by Region
2.2.1 Global Kidney-on-a-chip Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Kidney-on-a-chip Historic Market Size by Region (2018-2023)
2.2.3 Kidney-on-a-chip Forecasted Market Size by Region (2024-2029)
2.3 Kidney-on-a-chip Market Dynamics
2.3.1 Kidney-on-a-chip Industry Trends
2.3.2 Kidney-on-a-chip Market Drivers
2.3.3 Kidney-on-a-chip Market Challenges
2.3.4 Kidney-on-a-chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney-on-a-chip Players by Revenue
3.1.1 Global Top Kidney-on-a-chip Players by Revenue (2018-2023)
3.1.2 Global Kidney-on-a-chip Revenue Market Share by Players (2018-2023)
3.2 Global Kidney-on-a-chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kidney-on-a-chip Revenue
3.4 Global Kidney-on-a-chip Market Concentration Ratio
3.4.1 Global Kidney-on-a-chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney-on-a-chip Revenue in 2022
3.5 Kidney-on-a-chip Key Players Head office and Area Served
3.6 Key Players Kidney-on-a-chip Product Solution and Service
3.7 Date of Enter into Kidney-on-a-chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney-on-a-chip Breakdown Data by Type
4.1 Global Kidney-on-a-chip Historic Market Size by Type (2018-2023)
4.2 Global Kidney-on-a-chip Forecasted Market Size by Type (2024-2029)
5 Kidney-on-a-chip Breakdown Data by Application
5.1 Global Kidney-on-a-chip Historic Market Size by Application (2018-2023)
5.2 Global Kidney-on-a-chip Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Kidney-on-a-chip Market Size (2018-2029)
6.2 North America Kidney-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Kidney-on-a-chip Market Size by Country (2018-2023)
6.4 North America Kidney-on-a-chip Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney-on-a-chip Market Size (2018-2029)
7.2 Europe Kidney-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Kidney-on-a-chip Market Size by Country (2018-2023)
7.4 Europe Kidney-on-a-chip Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney-on-a-chip Market Size (2018-2029)
8.2 Asia-Pacific Kidney-on-a-chip Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Kidney-on-a-chip Market Size by Region (2018-2023)
8.4 Asia-Pacific Kidney-on-a-chip Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney-on-a-chip Market Size (2018-2029)
9.2 Latin America Kidney-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Kidney-on-a-chip Market Size by Country (2018-2023)
9.4 Latin America Kidney-on-a-chip Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney-on-a-chip Market Size (2018-2029)
10.2 Middle East & Africa Kidney-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Kidney-on-a-chip Market Size by Country (2018-2023)
10.4 Middle East & Africa Kidney-on-a-chip Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Kidney-on-a-chip Introduction
11.1.4 Emulate Revenue in Kidney-on-a-chip Business (2018-2023)
11.1.5 Emulate Recent Development
11.2 Tissuse
11.2.1 Tissuse Company Detail
11.2.2 Tissuse Business Overview
11.2.3 Tissuse Kidney-on-a-chip Introduction
11.2.4 Tissuse Revenue in Kidney-on-a-chip Business (2018-2023)
11.2.5 Tissuse Recent Development
11.3 Hesperos
11.3.1 Hesperos Company Detail
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Kidney-on-a-chip Introduction
11.3.4 Hesperos Revenue in Kidney-on-a-chip Business (2018-2023)
11.3.5 Hesperos Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Detail
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Kidney-on-a-chip Introduction
11.4.4 CN Bio Innovations Revenue in Kidney-on-a-chip Business (2018-2023)
11.4.5 CN Bio Innovations Recent Development
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Detail
11.5.2 Draper Laboratory Business Overview
11.5.3 Draper Laboratory Kidney-on-a-chip Introduction
11.5.4 Draper Laboratory Revenue in Kidney-on-a-chip Business (2018-2023)
11.5.5 Draper Laboratory Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Kidney-on-a-chip Introduction
11.6.4 Mimetas Revenue in Kidney-on-a-chip Business (2018-2023)
11.6.5 Mimetas Recent Development
11.7 Nortis
11.7.1 Nortis Company Detail
11.7.2 Nortis Business Overview
11.7.3 Nortis Kidney-on-a-chip Introduction
11.7.4 Nortis Revenue in Kidney-on-a-chip Business (2018-2023)
11.7.5 Nortis Recent Development
11.8 Kirkstall
11.8.1 Kirkstall Company Detail
11.8.2 Kirkstall Business Overview
11.8.3 Kirkstall Kidney-on-a-chip Introduction
11.8.4 Kirkstall Revenue in Kidney-on-a-chip Business (2018-2023)
11.8.5 Kirkstall Recent Development
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Detail
11.9.2 Cherry Biotech SAS Business Overview
11.9.3 Cherry Biotech SAS Kidney-on-a-chip Introduction
11.9.4 Cherry Biotech SAS Revenue in Kidney-on-a-chip Business (2018-2023)
11.9.5 Cherry Biotech SAS Recent Development
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Detail
11.10.2 Else Else Kooi Laboratory Business Overview
11.10.3 Else Else Kooi Laboratory Kidney-on-a-chip Introduction
11.10.4 Else Else Kooi Laboratory Revenue in Kidney-on-a-chip Business (2018-2023)
11.10.5 Else Else Kooi Laboratory Recent Development
11.11 Micronit Microtechnologies B.V.
11.11.1 Micronit Microtechnologies B.V. Company Detail
11.11.2 Micronit Microtechnologies B.V. Business Overview
11.11.3 Micronit Microtechnologies B.V. Kidney-on-a-chip Introduction
11.11.4 Micronit Microtechnologies B.V. Revenue in Kidney-on-a-chip Business (2018-2023)
11.11.5 Micronit Microtechnologies B.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
听
听
*If Applicable.
